Nguyen AnhCo (CIK 0001977970)

Latest company ownership

ATRA - Atara Biotherapeutics, Inc.

Role: CEO

Shares held

64,974

Last filed at

Nov 19, 2025

Confidence Score

46.3

2025Q4

Confidence Score History

2023Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 17, 2025	Nov 19, 2025	Atara Biotherapeutics, Inc.	CEO	Sell	46.3	-2,915	-4.29%	✗	$38.4K
Aug 18, 2025	Aug 20, 2025	Atara Biotherapeutics, Inc.	CEO	Sell	46.3	-2,958	-4.18%	✗	$34.4K
May 16, 2025	May 20, 2025	Atara Biotherapeutics, Inc.	CEO	Sell	46.3	-3,276	-4.42%	✗	$22.2K
Mar 3, 2025	Mar 5, 2025	Atara Biotherapeutics, Inc.	CEO	Sell	46.3	-3,331	-4.30%	✗	$23.3K
Nov 18, 2024	Nov 20, 2024	Atara Biotherapeutics, Inc.	CEO	Sell	46.3	-1,664	-2.10%	✗	$18.6K
Aug 16, 2024	Aug 20, 2024	Atara Biotherapeutics, Inc.	EVP, Chief Sci. & Tech Officer	Sell	46.3	-1,821	-5.07%	✗	$12.1K
May 16, 2024	May 20, 2024	Atara Biotherapeutics, Inc.	EVP, Chief Sci. & Tech Officer	Sell	46.3	-42,899	-4.56%	✗	$26.5K
Mar 4, 2024	Mar 6, 2024	Atara Biotherapeutics, Inc.	EVP, Chief Sci. & Tech Officer	Sell	47.5	-10,746	-1.13%	✗	$7.7K
Nov 16, 2023	Nov 20, 2023	Atara Biotherapeutics, Inc.	EVP, Chief Sci. & Tech Officer	Sell	47.5	-8,856	-3.10%	✗	$3.4K
Aug 16, 2023	Aug 18, 2023	Atara Biotherapeutics, Inc.	EVP, Chief Sci. & Tech Officer	Sell	46.3	-15,126	-5.02%	✗	$25K